[go: up one dir, main page]

IL143356A0 - An oral formulation for gastrointestinal drug delivery - Google Patents

An oral formulation for gastrointestinal drug delivery

Info

Publication number
IL143356A0
IL143356A0 IL14335699A IL14335699A IL143356A0 IL 143356 A0 IL143356 A0 IL 143356A0 IL 14335699 A IL14335699 A IL 14335699A IL 14335699 A IL14335699 A IL 14335699A IL 143356 A0 IL143356 A0 IL 143356A0
Authority
IL
Israel
Prior art keywords
layer
drug
drug delivery
oral formulation
protecting
Prior art date
Application number
IL14335699A
Other languages
English (en)
Original Assignee
Takada Kanji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takada Kanji filed Critical Takada Kanji
Publication of IL143356A0 publication Critical patent/IL143356A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL14335699A 1998-11-27 1999-11-26 An oral formulation for gastrointestinal drug delivery IL143356A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35396698 1998-11-27
JP26643399 1999-09-21
PCT/JP1999/006602 WO2000032172A1 (en) 1998-11-27 1999-11-26 An oral formulation for gastrointestinal drug delivery

Publications (1)

Publication Number Publication Date
IL143356A0 true IL143356A0 (en) 2002-04-21

Family

ID=26547440

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14335699A IL143356A0 (en) 1998-11-27 1999-11-26 An oral formulation for gastrointestinal drug delivery

Country Status (17)

Country Link
US (1) US7097851B1 (zh)
EP (1) EP1135112B1 (zh)
JP (1) JP4497725B2 (zh)
KR (1) KR100762475B1 (zh)
CN (1) CN1161107C (zh)
AT (1) ATE279914T1 (zh)
AU (1) AU766293B2 (zh)
BR (1) BR9916871A (zh)
CA (1) CA2352389C (zh)
DE (1) DE69921353T2 (zh)
DK (1) DK1135112T3 (zh)
ES (1) ES2233106T3 (zh)
HK (1) HK1043545A1 (zh)
ID (1) ID29085A (zh)
IL (1) IL143356A0 (zh)
MX (1) MXPA01005346A (zh)
WO (1) WO2000032172A1 (zh)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4990465B2 (ja) * 2000-05-26 2012-08-01 ▲高▼田 ▲寛▼治 ３層構造を有する非経口用製剤
WO2002064148A2 (en) * 2001-02-16 2002-08-22 Shimizu Pharmaceutical Co., Ltd. Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
DE10120092B4 (de) 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
US20060034929A1 (en) * 2001-12-27 2006-02-16 Brubaker Michael J Sustained release drug delivery devices with prefabricated permeable plugs
US8526466B2 (en) 2002-07-15 2013-09-03 At&T Intellectual Property I, L.P. Apparatus and method for prioritizing communications between devices
US8275371B2 (en) * 2002-07-15 2012-09-25 At&T Intellectual Property I, L.P. Apparatus and method for providing communications and connection-oriented services to devices
US8543098B2 (en) 2002-07-15 2013-09-24 At&T Intellectual Property I, L.P. Apparatus and method for securely providing communications between devices and networks
US8554187B2 (en) 2002-07-15 2013-10-08 At&T Intellectual Property I, L.P. Apparatus and method for routing communications between networks and devices
US7200424B2 (en) 2002-07-15 2007-04-03 Bellsouth Intelectual Property Corporation Systems and methods for restricting the use and movement of telephony devices
TWI355276B (en) 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP5105578B2 (ja) 2003-11-05 2012-12-26 サーコード バイオサイエンス インコーポレイテッド 細胞接着のモジュレーター
WO2006026556A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Bioadhesive rate-controlled oral dosage formulations
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
JP4606748B2 (ja) * 2004-02-06 2011-01-05 京セラケミカル株式会社 固形製剤の製造方法
TW200539903A (en) * 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
AT502098B8 (de) 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
JP4787503B2 (ja) * 2005-01-12 2011-10-05 京セラケミカル株式会社 固形製剤の製造方法
JP4787507B2 (ja) * 2005-01-24 2011-10-05 京セラケミカル株式会社 固形製剤及びその製造方法
JP2008155067A (ja) * 2005-04-14 2008-07-10 Toray Eng Co Ltd マイクロカプセル製造方法、マイクロカプセル製造装置、およびマイクロカプセルシート
PL2444079T3 (pl) 2005-05-17 2017-07-31 Sarcode Bioscience Inc. Kompozycje i sposoby leczenia chorób oczu
US20100233243A1 (en) * 2006-01-19 2010-09-16 Toray Engineering Co., Ltd. Laminated Microcapsule Sheet and Process For Production Thereof
JP2007246412A (ja) * 2006-03-14 2007-09-27 Serubakku:Kk 消化管用経口製剤とその製造方法および消化管用経口カプセル剤
JPWO2008053683A1 (ja) 2006-10-12 2010-02-25 東レエンジニアリング株式会社 マイクロカプセルシート
CA2681432A1 (en) * 2007-03-30 2008-10-23 Lintec Corporation Film-like orally administered medication and manufacturing method therefor
EP2152244B1 (en) * 2007-04-26 2015-12-02 Technion Research & Development Foundation Ltd. Oral administration of proteins and peptides
US8789536B2 (en) 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8303573B2 (en) 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
JP5808037B2 (ja) 2007-10-19 2015-11-10 サーコード バイオサイエンス インク． 糖尿病性網膜症の治療のための組成物及び方法
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
MX373366B (es) 2008-08-15 2025-03-05 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para administracion oral.
JP2013501071A (ja) 2009-08-06 2013-01-10 アイロンウッド ファーマシューティカルズ， インコーポレイテッド リナクロチドを含む処方物
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
AU2010339907A1 (en) 2009-12-16 2012-07-05 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
AU2011218009B2 (en) 2010-02-17 2016-11-03 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
SI2603232T1 (sl) 2010-08-11 2020-03-31 Ironwood Pharmaceuticals, Inc. Stabilne formulacije linaklotida
WO2012024767A1 (en) * 2010-08-25 2012-03-01 Grant Rufus Sparling Ii Improved enteric active substance delivery
EP2646006B1 (en) * 2010-11-26 2015-02-25 University Of The Witwatersrand, Johannesburg A pharmaceutical dosage form
US9708371B2 (en) 2011-08-17 2017-07-18 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
US9822257B2 (en) 2012-07-23 2017-11-21 Crayola Llc Dissolvable films and methods of using the same
CN110922393A (zh) 2012-07-25 2020-03-27 诺华股份有限公司 Lfa-1抑制剂及其多晶型物
JP7260913B2 (ja) * 2017-06-27 2023-04-19 株式会社バイオセレンタック 粘膜付着性経口製剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
JPH07121859B2 (ja) * 1986-03-18 1995-12-25 第一製薬株式会社 徐放性カプセル剤
US5196202A (en) * 1986-09-01 1993-03-23 Teikoku Seiyaku Kabushiki Kaisha Sustained release dosage form
US5236713A (en) 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1995005416A2 (en) * 1993-08-19 1995-02-23 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US5637319A (en) 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE69722178T2 (de) * 1996-11-22 2003-11-27 Toray Industries, Inc. Therapeutischer wirkstoff für augenerkrankungen
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
EP1053752A1 (en) * 1998-02-10 2000-11-22 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release

Also Published As

Publication number Publication date
CA2352389C (en) 2009-01-20
JP4497725B2 (ja) 2010-07-07
EP1135112A1 (en) 2001-09-26
CA2352389A1 (en) 2000-06-08
KR20010086057A (ko) 2001-09-07
DK1135112T3 (da) 2005-02-14
AU766293B2 (en) 2003-10-16
AU1410100A (en) 2000-06-19
DE69921353D1 (de) 2004-11-25
JP2002531394A (ja) 2002-09-24
MXPA01005346A (es) 2003-03-27
WO2000032172A1 (en) 2000-06-08
BR9916871A (pt) 2001-08-21
HK1043545A1 (zh) 2002-09-20
ES2233106T3 (es) 2005-06-01
KR100762475B1 (ko) 2007-10-04
EP1135112B1 (en) 2004-10-20
DE69921353T2 (de) 2005-11-10
ATE279914T1 (de) 2004-11-15
US7097851B1 (en) 2006-08-29
ID29085A (id) 2001-07-26
CN1161107C (zh) 2004-08-11
CN1333680A (zh) 2002-01-30

Similar Documents

Publication Publication Date Title
IL143356A0 (en) An oral formulation for gastrointestinal drug delivery
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
AU8781798A (en) Sustained release drug delivery system suitable for oral administration
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
AU6776700A (en) Implantable drug delivery catheter system with capillary interface
CA2329128A1 (en) Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
AU2002363998A1 (en) Bioadhesive drug delivery system with enhanced gastric retention
AU6141199A (en) Multiplex drug delivery system suitable for oral administration
AU4947100A (en) Drug delivery device
NZ513700A (en) Oral drug delivery system
AU7796198A (en) Novel acoustically active drug delivery systems
AU4496900A (en) Improved drug delivery pack
AU4681200A (en) A pharmaceutical composition of concentrates for microemulsion and self-emulsifying drug delivery system
AU1529397A (en) Delivery system for localized administration of medicaments to the upper respiratory tract
AU5060499A (en) Hydrodynamically balanced oral drug delivery system
AU3837999A (en) Drug delivery device
AU1751997A (en) Targeted delivery of drugs to the lower gastrointestinal tract
FR2796287B1 (fr) Dispositif d'administration de medicament
AU6503399A (en) Drug delivery catheter
AU2003275006A1 (en) Aerosol drug delivery system employing formulation pre-heating
AU3055099A (en) A pharmaceutical formulation for nasal administration
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
AU9587198A (en) Immediate release drug delivery forms
AU7965000A (en) Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same